An experimental drug compound could be a promising treatment for harmful diabetes complications, per a new study in lab mice ...

New research reveals metformin may reduce exercise benefits for diabetes patients, affecting blood sugar control and fitness ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, Nov. 12, 2025 (HealthDay News) — A common diabetes drug could be sabotaging ...

The European Medicines Agency's committee has recommended approval of French drugmaker Sanofi's first-of-its-kind drug that ...

New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...

Scientists warn common diabetes drug may be cancelling out benefits of exercise - New study raises urgent questions about how ...

Hospitalized patients with diabetes require specialized management to reduce readmission rates and complications. Newer ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

Tens of millions of people with type 2 diabetes might actually be undermining their efforts to improve their health, with researchers demonstrating that the commonly prescribed metformin blocks the ...

Diabetes drugs such as semaglutide already have a reputation for lowering the risk of cardiovascular events in people with ...

GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...

Managing diabetes requires understanding how certain foods and drinks interact with medications. High-fat foods, added sugars ...